Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Eli Lilly Drug Test Result; AbbVie Beat; WBD Layoffs | Stock Movers
Posted
July 31, 2025
Views
255
July 31, 2025
255
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
4:13
3:27Now PlayingOn this episode of Stock Movers:
- Eli Lilly (LLY) shares are moving on news the company's diabetes drug Mounjaro was as good at preventing heart attacks and strokes as its older medicine Trulicity in a head-to-head study. According to Bloomberg Intelligence analyst Michael Shah, the study's results will "likely be received negatively by the market" because Mounjaro was not meaningfully better than Trulicity.
- AbbVie (ABBV) shares are getting a lift after AbbVie raised its full-year profit forecast due to booming sales from newer immunology drugs that beat Wall Street's estimates. The company's quarterly sales were $15.42 billion, above the average analyst estimate of $15 billion, with adjusted earnings of $2.97 a share, a 12% increase.
- Warner Bros Discovery (WBD) shares are moving on news it is enacting a round of layoffs that will see jobs cut across its marketing, production strategy, operations and theatre ventures divisions. Roughly 10% of the studio’s workforce will be impacted, according to Variety.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Eli Lilly Drug Test Result; AbbVie Beat; WBD Layoffs
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
